2006
DOI: 10.1159/000093672
|View full text |Cite
|
Sign up to set email alerts
|

Modulating the Progression in IgA Nephropathy

Abstract: IgA nephropathy affects almost 1% of the population and yet the diagnosis is often missed. This significant kidney disease is often progressive with 25% of the patients going on to end-stage kidney disease over the course of 25 years. This minireview describes the clinical presentations in children and young adults. Therapeutic options are discussed including angiotensin-converting enzyme blockade, steroids, cytotoxics, tonsillectomy, fish oil, vitamin E, singly or in combination, in order to modulate the rate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
16
0
1

Year Published

2007
2007
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(19 citation statements)
references
References 137 publications
2
16
0
1
Order By: Relevance
“…The peak incidence of IgAN in children occurs between 9-10 years of age. 2 In the present study mean age of disease presentation was 10 ± 3.5 years, which is similar to above study. IgA nephropathy is more common in males than female 2 but here male to female ratio is 1:2.…”
Section: Resultssupporting
confidence: 91%
See 1 more Smart Citation
“…The peak incidence of IgAN in children occurs between 9-10 years of age. 2 In the present study mean age of disease presentation was 10 ± 3.5 years, which is similar to above study. IgA nephropathy is more common in males than female 2 but here male to female ratio is 1:2.…”
Section: Resultssupporting
confidence: 91%
“…1,2 The clinical presentations of IgA nephropathy varies across the spectrum of initial renal menifestations, ranging from gross hematuria to acute nephritic syndrome 3 . Sometimes some patients also manifests with End stage renal disease.…”
Section: Introductionmentioning
confidence: 99%
“…IgA nephropathy (IgAN) is the most common primary glomerulonephritis in children and adolescents worldwide [1,2]. The disease was described as a new clinical entity in 1968 [2].…”
Section: Introductionmentioning
confidence: 99%
“…The disease was described as a new clinical entity in 1968 [2]. Kidney biopsy is essential for diagnoses and shows a markedly expanded mesangium filled with IgA.…”
Section: Introductionmentioning
confidence: 99%
“…Medications may be added or changed postdiagnosis. 1,9 Some researchers [13][14][15] have examined the efficacy of fish oils and increased vitamin E intake to help control symptoms of IgA nephropathy, especially in the early stages or with unconfirmed test results. Cardiovascular complications are more common in patients who are smokers or who have hypertension.…”
mentioning
confidence: 99%